Vaccine Design, Development, and Delivery
A section of Vaccines (ISSN 2076-393X).
Section Information
Aims
This Section aims to highlight the latest advances in the design and development of both traditional and next-generation vaccines, which hold promise for providing solutions to challenging targets for which conventional approaches have proven ineffective. We strive to discuss emerging approaches to vaccine design and engineering based on recent insights into immunology, immune engineering, and novel immunological mechanisms, as well as translational applications and the development of next-generation therapeutic vaccines.
Scope
The Section welcomes high-quality papers that explore the design, development, and delivery of attenuated, inactivated, live, subunit, and vectored vaccines, the use of adjuvants in any formulation, and mechanisms involved in the immune responses. Advancements in the field are poised to enhance the efficacy and safety of vaccines, as well as to develop non-invasive delivery mechanisms. We encourage you to submit an original research paper or review article for peer review.
Keywords
- vaccine design
- traditional vaccine
- next-generation vaccine
- therapeutic vaccine
- non-invasive delivery
- mucosal and systemic vaccine
- adjuvants
- immunity
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Recent Research on Adenovirus-Vectored Vaccines (Deadline: 31 May 2026)
- Advances in the Use of Nanoparticles for Vaccine Platform Development: 2nd Edition (Deadline: 31 May 2026)
- Novel Adjuvants and Delivery Technologies for Vaccine Development (Deadline: 31 May 2026)
- State-of-the-Art Vaccine Design (Deadline: 30 June 2026)
- Next-Generation Platforms for Vaccine Design and Immune Evaluation (Deadline: 31 July 2026)
- The Critical Role of Adjuvants in Modern Vaccinology (Deadline: 15 August 2026)
- Strategies of Viral Vectors for Vaccine Development—2nd Edition (Deadline: 30 September 2026)
- Nanomaterial Application in Vaccines (Deadline: 30 September 2026)
- Research in Vaccine Adjuvants: Innovations and Challenges (Deadline: 20 October 2026)
- New Approaches to Vaccine Development and Delivery—2nd Edition (Deadline: 31 October 2026)
- Recent Advances in Virus-Like Particle-Based Vaccines (Deadline: 31 October 2026)
- Advances, Challenges, and Future Directions in Inactivated Vaccine Technology (Deadline: 31 October 2026)
- Bacterial Vectored Vaccines: Design and Application (Deadline: 31 October 2026)
- Novel Vaccine Designs to Enhance the Engagement of Innate and Adaptive Immunity (Deadline: 30 November 2026)
- Virus-Like Particle (VLP) Vaccines Against Emerging Infectious Diseases—2nd Edition (Deadline: 30 November 2026)
- Mucosal Vaccines: Advances in Technology and Delivery (Deadline: 30 November 2026)
- Advances in Vaccine and Adjuvant Design for Emerging and Re-Emerging Viral Pathogens (Deadline: 31 December 2026)
- Vaccine Design and Development (Deadline: 31 January 2027)
- Nanoparticle-Based Delivery Systems for Vaccines (Deadline: 31 January 2027)
- Innovations in Vaccine Technology—2nd Edition (Deadline: 1 February 2027)
- Next-Generation Vaccine Platforms for Emerging Infections (Deadline: 28 February 2027)
- Molecular Tuning for Vaccine Immunity: Regulating Immune and Inflammatory Responses to Inform Vaccine Design (Deadline: 28 February 2027)
- Next-Generation Vaccines Based on Recombinant Proteins, Antibodies and Nucleic Acids (Deadline: 31 March 2027)
